Innovators

2010 Innovators

The Innovator Presentation track featured 31 novel research approaches that can move a field of research forward. Each 25-minute presentation was a tangible case study on an innovative, cross-sector approach to medical research, development, funding and/or partnering.

• Accelerated Cure Project Biorepository
  Presented by: Hollie Schmidt, Vice President of Scientific Operations, Accelerated Cure Project for Multiple Sclerosis
  2:30 pm – 2:55 pm
  Room: Alvin

• The Accelerator of Cancer Treatments in Children
  Presented by: Beth Anne Baber, Ph.D., M.B.A., Co-Founder and CEO, The Nicholas Conor Institute for Pediatric Cancer Research
  10:45 am – 11:10 am
  Room: Uris

• BioPontis Alliance
  Presented by: Barbara Handelin, President, BioPontis Alliance, LLC
  4:00 pm – 4:25 pm
  Room: Broadway

• Cancer Commons
  Presented by: Jay M. Tenenbaum, Chairman, CEO and Chief Scientist, CollabRx
  11:00 am – 11:25 am
  Room: Broadway

• Cancer E-Life Collaboration
  Presented by: Ken Buetow, Ph.D., Associate Director, Bioinformatics and Information Technology, National Cancer Institute and Jon Handler M.D., Chief Architect, Microsoft Health Solutions Group
  10:30 am – 10:55 am
  Room: Broadway

• Centre for Drug Research and Development
  Presented by: Natalie Dakers, President and CEO, Centre for Drug Research and Development
  10:15 am – 10:40 am
  Room: Broadway

• Cerebrospinal Fluid Quality Control Initiative
  Presented by: Maria Carrillo, Ph.D., Senior Director, Medical and Scientific Relations, Alzheimer's Association
  11:00 am – 11:25 am
  Room: Alvin

• Clinical Trial Comparator Arm Partnership
  Presented by: Sharon Terry, M.A., President and CEO, Genetic Alliance; Stephen Friend, M.D., Ph.D., President, Sage Bionetworks
  11:15 am – 11:40 am
  Room: Broadway

• DART Therapeutics
  Presented by: Eugene Williams, Chairman, DART Therapeutics, LLC
  3:30 pm – 3:55 pm
  Room: Broadway

• Discontinued Clinical Compound Library: Academic Drug Repositioning
  Presented by: Kate Marusina, Ph.D., Manager, Industry Alliances, Clinical and Translational Sciences Center, University of California, Davis
  4:00 pm – 4:25 pm
  Room: Alvin

• Enabling Molecularly Informed Cancer Medicine, National Cancer Institute
  Presented by: Richard Aragon, Ph.D., Director, IMAT Program, National Cancer Institute, and Anthony Dickherber, Ph.D., Office of the Director, National Cancer Institute 
  3:30 pm – 3:55 pm
  Room: Alvin

• The Epilepsy Study Consortium
  Presented by: Jacqueline A. French, M.D., President, and Joyce A. Cramer, President, Epilepsy Therapy 
  4:00 pm – 4:25 pm
  Room: Regency

• findAKUre
  Presented by: Dr. Nicolas Sireau, Chairman, AKU Society, United Kingdom, and Dr. Lakshminarayan Ranganath, Consultant Chemical Pathologist and Honorary Senior Lecturer, Royal Liverpool University Hospital, United Kingdom
  3:30 pm – 3:55 pm
  Room: Regency

• Global Health Portfolio, Foundation for the NIH
  Presented by: Scott E. Campbell, Ph.D., Executive Director and CEO, Foundation for the National Institutes of Health 
  10:45 am – 11:10 am
  Room: Alvin

• Health Impact Fund Pilot, Incentives for Global Health
  Presented by: Harvey Rubin, Professor of Medicine, University of Pennsylvania, and Chair of the Scientific Advisory Committee, Incentives for Global Health
  3:00 pm – 3:25 pm
  Room: Regency

• Health of Women Study
  Presented by: Naz Sykes, Executive Director, Dr. Susan Love Research Foundation
  10:15 am – 10:40 am
  Room: Alvin

• Hospital Medicine Reengineering Network
  Presented by: Aaron Abend, Managing Director–Data Warehousing, Recombinant Data Corporation 10:45 am – 11:10 am
  Room: Broadway

• International AIDS Vaccine Initiative, Innovation Fund
  Presented by: Seth Berkley, M.D., President and CEO, International AIDS Vaccine Initiative
  4:00 pm – 4:25 pm
  Room: Uris

• International Partnership for Microbicides
  Presented by: Pamela M. Norick, Chief of External Relations, and Michael E. Green, Executive Director of Resource Development, International Partnership for Microbicides 
  2:30 pm – 2:55 pm
  Room: Regency

• Ivy Genomics Based Medicine Project
  Presented by: Michael E. Berens, Ph.D., Director and Senior Investigator, Translational Genomics Research Institute
  3:30 pm – 3:55 pm
  Room: Uris

• LaunchPad Fund, Biomedical Innovation in Diabetes
  Presented by: Greg Fralish, Program Director, Translational Research, and Mark Crowell, Executive Director and Associate Vice President, Innovation Partnerships and Commercialization, University of Virginia
  2:30 pm – 2:55 pm
  Room: Broadway

• Melanoma Research Alliance Academic-Industrial Partnership Awards
  Presented by: Suzanne L. Topalian, M.D., Chief Science Officer, and Laura Brockway-Lunardi, Ph.D., Scientific Program Director, Melanoma Research Alliance
  3:00 pm – 3:25 pm
  Room: Uris

• Multiple Myeloma Research Foundation, Personalized Medicine Initiative
  Presented by: Kathy Giusti, Founder and CEO, Multiple Myeloma Research Foundation, and Gerald McDougall, Partner, PricewaterhouseCoopers, MMRF and MMRC Board Member
  10:30 am – 10:55 am
  Room: Alvin

• Neurofibromatosis Preclinical Consortium
  Presented by: Kim Hunter-Schaedle, Ph.D., Chief Scientific Officer, Children's Tumor Foundation
  11:15 am – 11:40 am
  Room: Uris

• OncoNet
  Presented by: Eliav Barr, Vice President, Oncology Clinical Research, Merck Research Laboratories
  3:00 pm – 3:25 pm
  Room: Alvin

• Parkinson's Progression Markers Initiative
  Presented by: Sohini Chowdhury, Vice President, Research Partnerships, Michael J. Fox Foundation for Parkinson's Research 
  11:15 am – 11:40 am

• Product Development Partnership for a Malaria Vaccine: PATH Malaria Vaccine Initiative, GlaxoSmithKline Biologicals
  Presented by: Christian Loucq, M.D., Director, PATH Malaria Vaccine Initiative
  10:30 am – 10:55 am
  Room: Uris

• Seaside Therapeutics, Merck, NIH, FRAXA, and Autism Speaks
  Presented by: Randall L. Carpenter, M.D., President and CEO, Seaside Therapeutics, and Linda Brady, Ph.D., Director, Division of Neuroscience & Basic Behavioral Science, National Institute of Mental Health
  2:30 pm – 2:55 pm
  Room: Uris
  
  
• Tolerx-Cancer Research Institute Acceleration Fund
  Presented by: Christopher Merrill, Director, Business Development, Tolerx, Inc., and Adam Kolom, Director, Cancer Vaccine Acceleration Fund, Cancer Research Institute
  11:00 am – 11:25 am
  Room: Uris